Urinary Iodine is Associated with Insulin Resistance in Subjects with Diabetes Mellitus Type 2

 

 Buy Article Permissions and Reprints

Abstract

Background:

Diabetes Mellitus (DM) is a major health problem worldwide and its prevalence in Saudi Arabia has reached 31.6%. Patients with diabetes mellitus are at an increased risk of thyroid disease. The purpose of this study was to examine the urinary excretion of iodine in type 2 DM (T2DM) patients, and to assess the clinical implication of iodine status on T2DM.

Methods:

A total of 266 adult Saudis aged 18–55 years (109 T2DM patients and 157 healthy controls) were randomly selected from the Riyadh Cohort Study. Subjects were assessed for anthropometry, morning blood chemistries including fasting glucose, and lipid profile; serum concentrations of leptin, adiponectin, resistin, insulin, aPAI, hsCRP, Ang II, TNF-α, TSH, T3, T4, urine creatinine, urine iodine were measured using specific assays.

Results:

The concentration of urine iodine was significantly lower in T2DM than in healthy control subjects (84.6±2.3 vs. 119.4±3.4, p<0.001), which remained significant after creatinine correction and controlling for age (p=0.01). Furthermore, urinary iodine is negatively correlated with waist, hips, SAD, glucose, insulin, HOMA-IR triglyceride, resistin, angiotensin II (Ang II), and CRP, while it was positively associated with TSH.

Conclusions:

The decreased levels of iodine concentration in T2DM patients and its likely deleterious effects on metabolic functions calls for a systematic approach to thyroid disease screening in diabetic patients. Routine annual urinary iodine determination is recommended and should target T2DM patients at risk of thyroid dysfunction.

• References

• 1 Zimmermann MB. Iodine deficiency. Endocr Rev 2009; 30: 376-408
  CrossrefPubMedGoogle Scholar
• 2 ICCIDD/UNICEF/WHO . Global prevalence of iodine deficiency disorders. MDIS working Micronutrient deficiency information system. Geneva: World Health Organization; 1993
  Google Scholar
• 3 WHO W-H-O. Report on the intercountry training workshop for IDD laboratory managers. WHO—EM/Nut/130-E/L 1992
  PubMedGoogle Scholar
• 4 Dunn JT, Crutchfield HE, Gutekunst R et al. Two simple methods for measuring iodine in urine. Thyroid 1993; 3: 119-123
  CrossrefPubMedGoogle Scholar
• 5 Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004; 25: 1603-1610
  PubMedGoogle Scholar
• 6 Abu-Eshy SA, Al-Shehri MY, Khan A et al. Causes of goiter in the Asir region: a histopathological analysis of 361 cases. Ann Saudi Med 1994; 11: 285-288
  PubMedGoogle Scholar
• 7 Al-Tameem M. The pattern of surgically treated thyroid disease in two general hospitals in Riyadh. Saudi Med J 1987; 8: 61-66
  PubMedGoogle Scholar
• 8 Alzahrani AS, Aldasouqi S, Salam SA. et al. Autoimmune thyroid disease with fluctuating thyroid function. PLoS Med 2005; 2: e89
  CrossrefPubMedGoogle Scholar
• 9 Koriech OM. AKR. Thyroid cancer: clinicopathological study of 113 cases In Saudi Arabia. Saudi Med J 1988; 9: 188-193
  PubMedGoogle Scholar
• 10 Feely J, Isles TE. Screening for thyroid dysfunction in diabetics. Br Med J 1979; 1: 1678
  CrossrefPubMedGoogle Scholar
• 11 Gray RS, Irvine WJ, Clarke BF. Screening for thyroid dysfunction in diabetics. Br Med J 1979; 2: 1439
  PubMedGoogle Scholar
• 12 Kordonouri O, Klinghammer A, Lang EB et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002; 25: 1346-1350
  CrossrefPubMedGoogle Scholar
• 13 Perros P, McCrimmon RJ, Shaw G et al. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995; 12: 622-627
  CrossrefPubMedGoogle Scholar
• 14 Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 2006; 91: 1210-1217
  CrossrefPubMedGoogle Scholar
• 15 Kim SR, Tull ES, Talbott EO et al. A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Med Hypotheses 2002; 59: 660-666
  CrossrefPubMedGoogle Scholar
• 16 Wennlund A, Felig P, Hagenfeldt L et al. Hepatic glucose production and splanchnic glucose exchange in hyperthyroidism. J Clin Endocrinol Metab 1986; 62: 174-180
  CrossrefPubMedGoogle Scholar
• 17 Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab 2005; 90: 5317-5320
  CrossrefPubMedGoogle Scholar
• 18 Maxon HR, Kreines KW, Goldsmith RE et al. Long-term observations of glucose tolerance in thyrotoxic patients. Arch Intern Med 1975; 135: 1477-1480
  CrossrefPubMedGoogle Scholar
• 19 Dimitriadis G, Baker B, Marsh H et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985; 248: E593-E601
  PubMedGoogle Scholar
• 20 O'Meara NM, Blackman JD, Sturis J et al. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. J Clin Endocrinol Metab 1993; 76: 79-84
  CrossrefPubMedGoogle Scholar
• 21 WHO/NHD/01.1. Assessment of Iodine Deficiency Disorders and Monitoring their Elimination. A guide for program managers 2001; Second edition WHO/NHD/01.1: 2001
  PubMedGoogle Scholar
• 22 Pallardo LF, Pericas I, Jolin T. Thyroid iodine uptake, thyroid iodine secretion and plasma TSH levels in male rats during the day and night. Acta Endocrinol (Copenh) 1976; 82: 517-529
  PubMedGoogle Scholar
• 23 Mansourian AR. A review on the metabolic disorders of iodine deficiency. Pak J Biol Sci 2011; 14: 412-424
  CrossrefPubMedGoogle Scholar
• 24 Skrypnyk NV. Correlation between adipocytokines with iodine deficiency criteria in patients with metabolic syndrome and type 2 diabetes mellitus in Carpathians region. Lik Sprava 70-77
  PubMedGoogle Scholar
• 25 Lai Y, Wang J, Jiang F et al. The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J 58: 23-30
  PubMedGoogle Scholar
• 26 Moulopoulos DS, Koutras DA, Mantzos J et al. The relation of serum T4 and TSH with the urinary iodine excretion. J Endocrinol Invest 1988; 11: 437-439
  PubMedGoogle Scholar
• 27 Roos A, Bakker SJ, Links TP et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007; 92: 491-496
  CrossrefPubMedGoogle Scholar
• 28 Hatch M, Polyanskaya O, McConnell R et al. Urinary Iodine and Goiter Prevalence in Belarus: experience of the Belarus-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl nuclear accident. Thyroid 21: 429-437
  PubMedGoogle Scholar
• 29 Lee YK, Kim JE, Oh HJ et al. Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J Intern Med 26: 432-439
  PubMedGoogle Scholar
• 30 Pearce EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97: 326-333
  PubMedGoogle Scholar
• 31 Soriguer F, Valdes S, Morcillo S et al. Thyroid hormone levels predict the change in body weight: a prospective study. Eur J Clin Invest 41: 1202-1209
  PubMedGoogle Scholar